A multiplex PCR-based DNA assay for the detection of paraoxonase gene cluster polymorphisms

Atherosclerosis. 2001 Sep;158(1):35-40. doi: 10.1016/s0021-9150(00)00765-6.

Abstract

Paraoxonase (PON) is a high-density lipoprotein (HDL) associated protein which is supposed to protect low-density lipoprotein (LDL) against oxidation and to play a role in the development of atherosclerosis. Interindividual variability in serum PON activity is attributable to common variants in components of the PON gene cluster on chromosome 7. We describe experimental conditions that permit the simultaneous determination of three common PON polymorphisms (PON1-192, PON1-55 and PON2-311) that are tightly associated with an increased risk of atherosclerosis. We used a multiplex PCR-based DNA assay using mismatch primers that introduce a unique recognition site for the endonuclease HinfI in the PCR products in case of presence of the R allele of PON 1-192, of the L allele of PON1-55 and of the S allele of PON2-311. The restriction analysis with HinfI allows to identify an electrophoretic band pattern which is specific for the combination of the three polymorphisms. This technique could be applied in the association studies aimed at assessing the role of PON and their polymorphisms in many clinical settings. In a preliminary study on a small population sample from south Italy about 10% of chromosomes exhibited the presumed risk-related haplotype R(192)/L(55)/S(311).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Arteriosclerosis / enzymology
  • Arteriosclerosis / genetics*
  • Aryldialkylphosphatase
  • Chromosomes, Human, Pair 7
  • Esterases / blood
  • Esterases / genetics*
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Polymerase Chain Reaction / methods
  • Polymorphism, Genetic*
  • Risk Factors

Substances

  • Esterases
  • Aryldialkylphosphatase
  • PON1 protein, human